Vitamin D levels and asymptomatic coronary artery disease in type 2 diabetic patients with elevated urinary albumin excretion rate

Diabetes Care

Volumn 35, Issue 1, 2012, Pages 168-172

  Joergensen, Christel ^a   Reinhard, Henrik ^a   Schmedes, Anne ^b   Hansen, Peter R ^c   Wiinberg, Niels ^d   Petersen, Claus L ^d   Winther, Kaj ^d   Parving, Hans Henrik ^e,f   Jacobsen, Peter K ^a,e   Rossing, Peter ^a  

^a STENO DIABETES CENTER   (Denmark)

^b LILLEBAELT HOSPITAL   (Denmark)

^c GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^d FREDERIKSBERG HOSPITAL   (Denmark)

^e International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

^f AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; CALCIUM; VITAMIN D;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR DISEASE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY CALCIUM SCORE; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYOCARDIAL PERFUSION IMAGING; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PREVALENCE; SCORING SYSTEM; TANDEM MASS SPECTROMETRY; URINARY ALBUMIN EXCRETION RATE; URINARY EXCRETION; VITAMIN D DEFICIENCY;

ADULT; AGED; ALBUMINURIA; CALCIFEDIOL; CALCINOSIS; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; DENMARK; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; RISK FACTORS; VITAMIN D DEFICIENCY;

EID: 84859032140     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc11-1372     Document Type: Article

References (32)

1. Schurgin S, Rich S, Mazzone T. Increased prevalence of significant coronary artery calcification in patients with diabetes. Diabetes Care 2001;24:335-338 (Pubitemid 32119134)
2. Simons DB, Schwartz RS, Edwards WD, Sheedy PF, Breen JF, Rumberger JA. Non-invasive definition of anatomic coronary artery disease by ultrafast computed tomographic scanning: a quantitative pathologic comparison study. J Am Coll Cardiol 1992;20:1118-1126
3. Rumberger JA, Simons DB, Fitzpatrick LA, Sheedy PF, Schwartz RS. Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study. Circulation 1995;92:2157-2162
4. Raggi P, Callister TQ, Cooil B, et al. Identification of patients at increased risk of first unheralded acute myocardial infarction by electron-beam computed tomography. Circulation 2000;101:850-855 (Pubitemid 30117879)
5. Arad Y, Spadaro LA, Goodman K, Newstein D, Guerci AD. Prediction of coronary events with electron beamcomputed tomography. J Am Coll Cardiol 2000;36:1253-1260
6. Michos ED, Streeten EA, Ryan KA, et al. Serum 25-hydroxyvitamin Dlevels are not associated with subclinical vascular disease or C-reactive protein in the old order Amish. Calcif Tissue Int 2009;84:195-202
7. de Boer IH, Kestenbaum B, Shoben AB, Michos ED, Sarnak MJ, Siscovick DS. 25-hydroxyvitamin Dlevels inversely associate with risk for developing coronary artery calcification. J Am Soc Nephrol 2009;20:1805-1812
8. Young KA, Snell-Bergeon JK, Naik RG, et al. Vitamin Ddeficiency and coronary artery calcification in subjects with type 1 diabetes. Diabetes Care 2011;34:454-458
9. Cigolini M, Iagulli MP, Miconi V, Galiotto M, Lombardi S, Targher G. Serum 25-hydroxyvitamin D3concentrations and prevalence of cardiovascular disease among type 2 diabetic patients. Diabetes Care 2006;29:722-724 (Pubitemid 44115386)
10. Dobnig H, Pilz S, Scharnagl H, et al. Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med 2008;168:1340-1349 (Pubitemid 351930842)
11. Joergensen C, Gall MA, Schmedes A, Tarnow L, Parving H-H, Rossing P. Vitamin Dlevels and mortality in type 2 diabetes. Diabetes Care 2010;33:2238-2243
12. Tarnow L, Gall M-A, Hansen BV, Hovind P, Parving H-H. Plasma N-terminal pro-B-type natriuretic peptide and mortality in type 2 diabetes. Diabetologia 2006;49:2256-2262 (Pubitemid 44359085)
13. Reinhard H, Hansen PR, Persson F, et al. Elevated NT-proBNP and coronary calcium score in relation to coronary artery disease in asymptomatic type 2 diabetic patients with elevated urinary albumin excretion rate. Nephrol Dial Transplant 2011;26:3242-3249
14. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990;15:827-832 (Pubitemid 20101575)
15. Raggi P, Shaw LJ, Berman DS, Callister TQ. Prognostic value of coronary artery calcium screening in subjects with and without diabetes. J Am Coll Cardiol 2004;43:1663-1669 (Pubitemid 38561350)
16. Anand DV, Lim E, Hopkins D, et al. Risk stratification inuncomplicated type 2 diabetes: prospective evaluation of the combined use of coronary artery calcium imaging and selectivemyocardial perfusion scintigraphy. Eur Heart J 2006;27:713-721
17. Elkeles RS, Godsland IF, Feher MD, et al.; PREDICT Study Group. Coronary calcium measurement improves prediction of cardiovascular events in asymptomatic patients with type 2 diabetes: the PREDICT study. Eur Heart J 2008;29:2244-2251
18. Agarwal S, Morgan T, Herrington DM, et al. Coronary calcium score and prediction of all-cause mortality in diabetes: the Diabetes Heart Study. Diabetes Care 2011;34:1219-1224
19. Chiu YW, Adler SG, Budoff MJ, Takasu J, Ashai J, Mehrotra R. Coronary artery calcification and mortality in diabetic patients with proteinuria. Kidney Int 2010;77:1107-1114
20. Oudkerk M, Stillman AE, Halliburton SS, et al.; European Society of Cardiac Radiology; North American Society for Cardiovascular Imaging. Coronary artery calcium screening: current status and recommendations from the European Society of Cardiac Radiology and North American Society for Cardiovascular Imaging. Eur Radiol 2008;18:2785-2807
21. Knez A, Becker A, Leber A, et al. Relation of coronary calcium scores by electron beam tomography to obstructive disease in 2,115 symptomatic patients. Am J Cardiol 2004;93:1150-1152 (Pubitemid 38521046)
22. Beller GA. Noninvasive screening for coronary atherosclerosis and silent ischemia in asymptomatic type 2 diabetic patients: is it appropriate and cost-effective? J Am Coll Cardiol 2007;49:1918-1923 (Pubitemid 46694282)
23. Targher G, Bertolini L, Padovani R, et al. Serum 25-hydroxyvitamin D3concentrations and carotid artery intima-media thickness among type 2 diabetic patients. Clin Endocrinol (Oxf) 2006;65:593-597 (Pubitemid 44583818)
24. Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1,25-Dihydroxyvitamin D(3) is anegative endocrine regulator of the reninangiotensin system. J Clin Invest 2002;110:229-238 (Pubitemid 34787360)
25. Xiang W, Kong J, Chen S, et al. Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems. Am J Physiol Endocrinol Metab 2005;288:E125-E132 (Pubitemid 40023798)
26. Zehnder D, Quinkler M, Eardley KS, et al. Reduction of the vitamin D hormonal system in kidney disease is associatedwith increased renal inflammation. Kidney Int 2008;74:1343-1353
27. Van den Berghe G, Van Roosbroeck D, Vanhove P, Wouters PJ, De Pourcq L, Bouillon R. Bone turnover in prolonged critical illness: effect of vitamin D. J Clin Endocrinol Metab 2003;88:4623-4632 (Pubitemid 37357503)
28. Timms PM, Mannan N, Hitman GA, et al. Circulating MMP9, vitamin Dand variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders? QJM 2002;95:787-796 (Pubitemid 36032948)
29. Mathew S, Lund RJ, Chaudhary LR, Geurs T, Hruska KA. Vitamin Dreceptor activators can protect against vascular calcification. J Am Soc Nephrol 2008;19:1509-1519
30. London GM, Marty C, Marchais SJ, Guerin AP, Metivier F, de Vernejoul MC. Arterial calcifications and bone histomorphometry in end-stage renal disease. J Am Soc Nephrol 2004;15:1943-1951 (Pubitemid 38822076)
31. Oh J, Weng S, Felton SK, et al. 1,25 (OH) 2vitamin D inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus. Circulation 2009;120:687-698
32. Kull M Jr, Kallikorm R, Tamm A, Lember M. Seasonal variance of 25-(OH) vitamin D in the general population of Estonia, a Northern European country. BMC Public Health 2009;9:22